TRIUMPH-3: Obesity with Established Cardiovascular Disease (July 2026) TRIUMPH-3 enrolled 1,949 adults with severe obesity (BMI 35) and established cardiovascular disease, with or without type 2 diabetes, randomized 1:1:2 to retatrutide 9mg, 12mg, or placebo over 80 weeks
The more common scenario is a lack of glutathione (not a lack of vitamin C)
The researchers compared the weight loss and metabolic effects of GLP1MK-801 with the GLP1 analogue alone, MK-801 alone and vehicle controls in diet-induced obese (DIO) mice, and found that GLP1MK-801 induced significantly greater weight loss than all other conditions over the 14-day treatment period
Others need them a little more often at first
Always discuss your complete medical history, including gallbladder removal, with your healthcare provider when considering Wegovy treatment to ensure personalised care and optimal results